Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 18191 VON KARMAN AVENUE, IRVINE, CA
- Founded
- Not disclosed
📈 Company Timeline
American Healthcare REIT, Inc. reported Regulation FD disclosure
American Healthcare REIT, Inc. filed an 8-K covering Regulation FD disclosure, another company event, supporting financial statements or exhibits.
American Healthcare REIT, Inc. reported Regulation FD disclosure
American Healthcare REIT, Inc. filed an 8-K covering Regulation FD disclosure.
American Healthcare REIT, Inc. reported A director or senior management change or compensation event
American Healthcare REIT, Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.
American Healthcare REIT, Inc. reported Regulation FD disclosure
American Healthcare REIT, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
American Healthcare REIT, Inc. reported Another company event
American Healthcare REIT, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.
Capital Structure & Financial Position
Financial strength and liquidity analysisSource: SEC EDGAR company facts (opens in a new tab) Balance sheet dated
Peer Comparison - Real Estate
| Company | Price | Market Cap |
|---|---|---|
| WELL - Welltower Inc. |
$235.98
Yahoo Finance |
$170.08B |
| PLD - Prologis, Inc. |
$128.69
Yahoo Finance |
$122.01B |
| BN - Brookfield Corporation |
$37.54
Yahoo Finance |
$92.00B |
| AMT - American Tower Corporation |
$180.61
Yahoo Finance |
$84.16B |
| BAM - Brookfield Asset Management Ltd. |
$45.93
Yahoo Finance |
$73.36B |
📋 Corporate Actions
Recent and upcoming corporate eventsFinancials
Financial statements and key metrics analysis| Quarter | Revenue (USD) | Operating income | Net income | Diluted EPS (USD) | Filed |
|---|---|---|---|---|---|
| Q2 2026 | $634.52M | $137.24M | $30.61M | $0.16 | 10-Q · 7 Aug 2026 |
| Q1 2026 | $609.77M | $125.50M | $23.71M | $0.13 | 10-Q · 8 May 2026 |
| Q4 2025 | $563.99M | $111.58M | $11.79M | Unavailable | 10-K · 27 Feb 2026 |
| Q3 2025 | $532.06M | $105.82M | $55.93M | $0.33 | 10-Q · 7 Nov 2025 |
| Q2 2025 | $501.29M | $103.23M | $9.91M | $0.06 | 10-Q · 8 Aug 2025 |
| Q1 2025 | $497.18M | $94.54M | −$6.80M | −$0.04 | 10-Q · 9 May 2025 |
Analyst Consensus
Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 55.00–70.00 Ratings are third-party opinions, not advice.
💰 Upcoming Dividends
Next dividend paymentsGuidance Evolution
💼 Director Transactions
Recent insider activityTop Shareholders
Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago